See What HealthDay Can Do For You
Contact Us

October 2010 Briefing - HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for October 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Primary Care Trails Other Specialties in Hourly Wages

TUESDAY, Oct. 26 (HealthDay News) -- Primary care physicians have substantially lower hourly wages than other specialists, and although most physicians find Medicare reimbursement inequitable, they show little consensus on how to reform it, according to two studies published in the Oct. 25 issue of the Archives of Internal Medicine.

Abstract - Leigh
Full Text (subscription or payment may be required)
Abstract - Federman
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

HIV Drug Invirase Gets New Label Reflecting Risk

THURSDAY, Oct. 21 (HealthDay News) -- New risk information has been added to the label of the HIV antiviral drug Invirase (saquinavir), notifying patients and health care professionals that the drug can have potentially life-threatening adverse effects when used in combination with another antiviral drug, according to an announcement by the U.S. Food and Drug Administration.

Press Release
More Information

Studies Assess Regimens After Nevirapine

WEDNESDAY, Oct. 13 (HealthDay News) -- In women with HIV-1 who have taken peripartum single-dose nevirapine, the use of ritonavir-boosted lopinavir with tenofovir-emtricitabine is associated with better outcomes than therapy featuring nevirapine, and in children with prior nevirapine exposure, benefits are seen with zidovudine and lamivudine plus ritonavir-boosted lopinavir, according to two studies published in the Oct. 14 issue of The New England Journal of Medicine.

Abstract - Lockman
Full Text (subscription or payment may be required)
Abstract - Palumbo
Full Text (subscription or payment may be required)

Age at Cancer Diagnosis Similar in AIDS, General Populations

TUESDAY, Oct. 5 (HealthDay News) -- After adjustment for the lower proportion of older-age patients among the AIDS population, most cancers in this population are diagnosed at an age similar to that in the general population, according to research published in the Oct. 5 issue of the Annals of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.